Brief: Diasorin Q2 Adj. EBITDA EUR 107 Mln
31/07/2025 15:24
July 31 (Reuters) - DiaSorin SpA DIAS.MI: CONFIRMS GUIDANCE 2025 Q2 NET PROFIT EUR 46 MILLION Q2 ADJUSTED EBITDA EUR 107 MILLION Q2 REVENUE EUR 306 MILLION ESTIMATED IMPACT FROM TARIFFS ON GROUP’S PROFITABILITY FOR FY 2025 IS NOT EXPECTED TO BE MATERIAL Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest